Recently, genetic studies of IPMN lead to discover mutations of new genes, including GNAS, and RNF43 (Macgregor-Das and Iacobuzio-Donahue 2013; Reid et al. 2014). This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.